[1] BRENDAN D MANNING L C C. AKT/PKB signaling: navigating downstream.[J]. Cell, 2007, 129 7: 1261-1274. DOI:
10.1016/j.cell.2007.06.009[2] T L YUAN L C C. PI3K pathway alterations in cancer: variations on a theme[J]. Oncogene, 2008, 27 41: 5497-5510. DOI:
10.1038/onc.2008.245[3] VIVEK BARVE. Synthesis, Molecular Characterization, and Biological Activity of Novel Synthetic Derivatives of Chromen-4-one in Human Cancer Cells[J]. Journal of Medicinal Chemistry, 2006, 49 13: 3800-3808. DOI:
10.1021/jm051068y[4] GABRIEL FRAMPTON. Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.[J]. Gut, 2012, 61 2: 268-277. DOI:
10.1136/gutjnl-2011-300643[5] MARK S RYBCHYN. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts.[J]. The Journal of Biological Chemistry, 2011: 23771-23779. DOI:
10.1074/jbc.m111.251116[6] N ZAREEN L A G S C Biswas. A feed-forward loop involving Trib3, Akt and FoxO mediates death of NGF-deprived neurons[J]. Cell Death and Differentiation, 2013, 20 12: 1719-1730. DOI:
10.1038/cdd.2013.128